/Investors

Omron Ventures — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Avails Medicalavailsmedical.comMar 2020

Avails Medical develops the eQUANT™ System, an FDA-cleared diagnostic platform using electronic biosensor technology for rapid antimicrobial susceptibility testing in infectious disease care.

Deep TechDigital HealthHealthtechMedical DevicesMenlo Park, US

Oren Knopfmacher(Executive Officer, Director)in

BoardMichael Laufer(Director)Nancy Isaac(Director)

Co-investorsAstia

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.